TS
FBRX icon

Thomas Steyer’s Forte Biosciences FBRX Stock Holding History

Thomas Steyer’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-70,429
Closed -$547K – 152
2025
Q1 		$547K Buy
70,429
+35,429
+101% +$418K ﹤0.01% 95
2024
Q4 		$795K Sell
35,000
-37,413
-52% -$445K ﹤0.01% 99
2024
Q3 		$406K Sell
72,413
-5
-0% -$51 ﹤0.01% 112
2024
Q2 		$972K Hold
72,418
– – ﹤0.01% 108
2024
Q1 		$1.27M Hold
72,418
– – 0.01% 118
2023
Q4 		$1.49M Hold
72,418
– – 0.01% 102
2023
Q3 		$1.2M Buy
+72,418
New +$1.61M 0.01% 111
2017
Q3 		– Sell
-267
Closed -$1.2M – 88
2017
Q2 		$1.2M Buy
+267
New +$1.5M 0.01% 81

Other funds holding FBRX

FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Thomas Steyer's FBRX Position: Q2 2025 in Review

Thomas Steyer sold out of Forte Biosciences (FBRX) in Q2 2025, closing a stake of 70,429 shares — an estimated $547K sold.

Thomas Steyer first reported a position in FBRX in Q2 2017 and held it in 8 quarters. The position peaked at $1.49M in Q4 2023. 33 funds tracked by Wall St. Rank hold FBRX as of Q2 2025.

  • Thomas Steyer reported no remaining Forte Biosciences position as of Q2 2025 after selling out during the quarter.
  • Thomas Steyer sold 70,429 Forte Biosciences shares in Q2 2025, an estimated $547K.
  • Thomas Steyer first reported a position in Forte Biosciences in Q2 2017 and held it in 8 quarters.
  • Thomas Steyer's Forte Biosciences position peaked at $1.49M in Q4 2023.
  • 33 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2025.

Based on Farallon Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.